TDOC Teladoc Health, Inc. Common Stock

NYSE · Health Care · Ver em SEC EDGAR ↗
$6,60
Preço · Ago 18, 2026
Fundamentais a partir de Jul 30, 2026

Sobre Teladoc Health, Inc. Common Stock Visão geral da empresa da Wikipedia

Teladoc Health, Inc. is an American telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services.

Ler mais

Teladoc Health, Inc. is an American telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services.

The company uses telephone and videoconferencing software and mobile apps to provide on-demand remote medical care. Teladoc Health is active in over 175 countries, and is traded on the New York Stock Exchange. It is the first and largest telemedicine company in the United States, and has acquired numerous other companies including BetterHelp in 2015, Best Doctors in 2017, and Catapult Health in 2025.

History

2002–2015

Teladoc was founded in 2002 in Dallas, Texas by G. Byron Brooks and Michael Gorton. It is the oldest and largest telemedicine company in the United States. Teladoc's initial business model allowed patients to remotely consult with state-licensed doctors at any time. Companies paid a monthly fee for their employees to access the service, while patients paid a flat fee for each consultation, originally about $35 to $40. With Gorton as both chairman and CEO, Teladoc launched nationally in 2005 at the Consumer Directed Health Care Conference in Chicago, Illinois. Teladoc had around 1 million members by the end of 2007, with large employers such as AT&T providing the service to employees as a health benefit. Jason Gorevic was named Teladoc's chief executive in 2009. In 2011, Aetna began offering Teladoc for its fully insured members in Florida and Texas, later offering Teladoc in all 50 states.

Teladoc acquired Consult A Doctor for $16.6 million cash in 2013, allowing smaller companies to access Teladoc's services. The Affordable Care Act led to a large number of insurance companies signing with Teladoc, resulting in a growth surge around 2014. By that time, insurance companies such as Blue Shield of California and Oscar had signed with Teladoc, as well as other companies such as Home Depot, T-Mobile, CalPERS, and Rent-A-Center. Teladoc acquired AmeriDoc for $17.2 million in May 2014. The acquisitions of Consult A Doctor and AmeriDoc, both Teladoc's main competitors, resulted in Teladoc becoming the largest telemedicine provider in the United States. After initial fundraising rounds in 2009, 2011, and 2013, Teladoc raised $50 million in 2014, bringing total funding to $100 million. Teladoc's sales doubled in both 2013 and 2014.

2015–2016

Teladoc Health became a public company on July 1, 2015 as the only telemedicine company on the New York Stock Exchange. Teladoc's initial public offering listed at $19 per share, giving the company a market capitalization of $758 million and an enterprise value of $620 million. The initial response to the IPO was positive, as shares surged 50% on the opening day. Three months after the IPO, health insurer Highmark, which represented 1.5% of Teladoc's 2015 revenue, ceased to renew a contract. Teladoc shares fell significantly as a result, before rising to earlier levels. That October, it was the first telehealth company to reach one million visits.

In 2015, Teladoc acquired the behavioral health services provider Compile Inc., operating as BetterHelp for $3.5 million, and competitor Stat Health Services (StatDoc) for $30 million. The following year Teladoc began aggressively expanding, acquiring other companies and launching health segments for dermatology, behavioral health, and sexual health. That year the company won a patent infringement lawsuit filed against competitor American Well.

In July 2016, Teladoc acquired HealthiestYou for $125 million ($45 million in cash and $80 million in stock). Teladoc had 15 million members by November 2016 and a market share of 75% in the United States. The largest national network of virtual care providers in the nation, its full-service suite was operational in 48 states, excluding Arkansas and Texas. In December 2016, the American Hospital Association exclusively endorsed Teladoc's telehealth technology platform. Teladoc logged 952,000 patient visits that year.

2017–2020

In its largest acquisition at the time, in 2017 Teladoc spent $440 million purchasing Best Doctors, a consultation firm and provider of medical second opinions and medical award listings. In 2019, ProPublica criticized companies such as Best Doctors for selling physician awards as pay-to-play. Teladoc had 7,500 clients in 2017, of which 220 were Fortune 1000 companies. Sales that year were $233 million, 89% higher than the year prior. Teladoc Health brands by 2018 included Teladoc, Advance Medical, Best Doctors, BetterHelp and HealthiestYou.

On August 10, 2018, Teladoc, Inc. changed its name to Teladoc Health, Inc. while continuing to trade on the NYSE. Teladoc Health began partnering with CVS in August 2018 on remote consults at MinuteClinics. Teladoc Health acquired Advance Medical, a telemedicine company employing doctors in Latin America, Europe, and Asia, for $352 million in 2018. In December 2018, Teladoc Health's chief financial officer and chief operating officer Mark Hirschhorn resigned after a report that he engaged in a sexual relationship and insider trading with an employee. According to Yahoo Finance, stock value fell roughly 20% in the days following, while an investor class action lawsuit alleged that Teladoc Health had violated securities laws by failing to disclose Hirschhorn's behavior. Teladoc Health denied making false statements or any legal violations.

Active in 130 countries by 2019; that year, Teladoc acquired the French health company MédecinDirect and launched in Canada with the Teladoc Telemedicine Service. Joining from American Express, Mala Murthy was appointed CFO in June 2019.

In March 2020, Teladoc was providing "near real-time" surveillance data on the spread of coronavirus to the CDC. In July 2020, Teladoc acquired InTouch Health. In October 2020, Teladoc acquired the chronic care company Livongo Health for $13.9 billion in a deal described by the press as the third-largest for a U.S. company that year. The combined companies had an estimated enterprise value of $37 billion. Teladoc then brought in Florida Blue as the first insurer to use Livongo's digital diabetes program. Teladoc sued Amwell in October 2020 for alleged copyright infringement on nine patents, settling the case in July 2022.

2021–2024

In early 2021, paid membership in the U.S. was 52 million. In January 2021, Teladoc began offering a diabetes management service through Dexcom. Later that year, Teladoc Health launched myStrength Complete, a "unified mental health care platform for its B2B customers." In June 2021, Teladoc sued the company Avail for allegedly infringing on three patents related to telemedicine consoles.

On July 14, 2021, Teladoc announced it was collaborating with Microsoft to combine its delivery platform for hospitals and health systems with Microsoft Teams. Teladoc introduced its primary care service Primary360 on a national scale in October 2021. The program gave members access to both a primary physician and care team, with a system in place for followup reminders about appointments and personal maintenance. In February 2022, Teladoc Health launched Chronic Care Complete, a program to help patients manage multiple chronic conditions.

Teladoc had a valuation of roughly $11.3 billion by February 2022, and warned investors there might be a goodwill write-down that year related to the Livongo acquisition. Teladoc announced that Amazon could newly access Teladoc through Alexa and related devices, in February 2022, sparking debate among antitrust experts about the potential impact on the health industry. Amazon Care was shut down later that year.

In April 2022, Northwell Health began using the Teladoc platform with its clinicians, starting with 20 hospitals in the system. After Teladoc's stock value fluctuated significantly during the coronavirus pandemic, the company, in June 2022, was sued by investors alleging it had misrepresented its financial prospects, particularly in regard to its BetterHelp mental health subsidiary and chronic care business. Characterizing the lawsuit, which was later dismissed, as "frivolous," in July 2022, Teladoc reported revenue growth above analysts' projections, with significant growth in BetterHelp. In August 2022, Teladoc became the telehealth portal for Mayo Clinic Health System patients in Onalaska, Wisconsin.

In 2023, the company relocated its headquarters to new York City. Charles "Chuck" Divita, III, was appointed CEO in June 2024, leading the company's further expansion. In July, the firm launched Wellbound employee assistance program (EAP), incorporating BetterHelp into its U.S. employer-sponsored health plans.

2025–present

In January 2025, the company added its virtual cardiometabolic programs to Amazon Health Services health benefits connector. That year, Teladoc Health made a series of acquisitions, including Catapult Health in February, mental healthcare company UpLift in April, and Australia's Telecare virtual care firm in August.

In March 2025, the FTC fined BetterHelp $7.8 million for sharing consumer data with third-party social media sites, banning the company from health data disclosures for advertising purposes. Subsequent to the dismissed June 2022 lawsuit, a new class-action was filed by investors in the U.S. District Court for the Southern District of New York on May 17, 2025.

The company reported over 100 million U.S. members in July 2025, and launched new AI capabilities for healthcare workplaces to monitor and mitigate violence that October. In November, Teladoc Health joined with Lumeris, Deloitte, Nuna and Unite Us as Collaborative for Healthy Rural America, pledging to build a shared, integrated care platform, following individual states' plan approvals from the new Rural Health Transformation (RHT) Program of the U.S. Department of Health and Human Services.

Services and business model

Headquartered in New York City, the company operates two main components: Teladoc Health Integrated Care, its virtual care business for health plans, employers and health networks, and BetterHelp direct-to-consumer virtual mental health care. As a technology company, Teladoc Health is involved with artificial intelligence, analytics, telehealth devices, and "licensable platform services." The company uses telephone and videoconferencing software to provide on-demand remote medical care, with patients able to log on to the service at any time and be connected with a board-certified, state-licensed physician. Its app combines all of its services and programs.

Contracting largely with insurers and large employers, hospitals and health systems, Teladoc Health generates revenue through an annual, or monthly, fee charged per subscriber, as well as a fee for individual consults. Some companies waive or subsidize the consult fee for their employees.

By July 2020, the company stated it served "60 of the top 100 hospitals," with telemedical robots being used at hospitals such as Providence Regional Medical Center in Everett, Washington and Sheba Medical Center in Israel, minimizing the potential spread of coronavirus. Numerous studies analyzing Teladoc's impact on the industry have been conducted.

Disaster aid

Teladoc Health provides free telehealth visits to communities affected by federally declared natural disasters and public emergencies in the United States, including to victims of incidents such as the 2018 Camp Fire in Paradise, California, Hurricane Ida in 2021, and the 2025 Southern California wildfires. In March 2023, it began providing free care to residents in Mississippi affected by recent tornadoes and, in 2024, to communities in several states that were impacted by Hurricanes Milton and Helene.

Lobbying and legislation

Teladoc Health has been involved in lobbying for legislation in several states. In 2015 the Texas Medical Board ruled that state physicians had to physically meet patients before remotely treating ailments or prescribing medication. The bill undermined Teladoc Health's business model in Texas, where it had around two million subscribers. Teladoc Health sued in federal court over the rule in Teladoc v. Texas Medical Board, arguing the bill violated antitrust laws by inflating prices and limiting the supply of health care providers in the state. The bill, meant to go active on June 3, 2015, was stalled while the lawsuit went through a federal appeals court, allowing Teladoc Health to continue operating in Texas in the interim. Teladoc voluntarily dropped the lawsuit in 2017 after Texas passed a new bill allowing for remote treatment without a prior in-person interaction, which Teladoc Health had lobbied heavily for.

In January 2019, Teladoc Health opposed a telemedicine bill proposed by the North Dakota Board of Medicine, which required telemedicine providers to perform initial video examinations or have initial exams done by another physician. Proponents argued the bill protected patients, while Teladoc Health and critics argued it decreased access to healthcare in rural areas. The year prior, Teladoc Health had completed 1,500 virtual visits in the state. In May 2019, the company created a virtual care patient safety organization (PSO) dubbed the Institute for Patient Safety and Quality of Virtual Care.

In December 2021, Teladoc along with the American Medical Association, American Hospital Association, AARP, Amazon, Walmart, and CVS formed Telehealth Access for America, a coalition pushing for the extension of telehealth policies implemented by U.S. Congress in response to the COVID-19 pandemic. Subsequently, U.S. Senators Bill Cassidy and Tammy Baldwin introduced the Health Data Use and Privacy Commission Act in February 2022, which proposes creating a commission to study modernizing health data and privacy laws. The proposed legislation was supported by Teladoc and organizations such as the American College of Cardiology, IBM, and the United Spinal Association.

Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗

Wikidata ↗

TDOC Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas

Preço
$6.60
Capitalização de Mercado
$1.19B
P/E (TTM)
-5.9
EPS (TTM)
$-1.14
Receita (TTM)
$2.53B
Rendimento div.
ROE
-14.3%
Dívida/Capital
Intervalo 52 Semanas
$4 – $10

TDOC Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização

Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS

Receita e Lucro Líquido $2.53B
10-point trend, +1954.3%
2016-12-31 2025-12-31
EPS $-1.14
7-point trend, +17.4%
2019-12-31 2025-12-31
Fluxo de caixa livre $285M
9-point trend, +870.0%
2017-12-31 2025-12-31
Margens -7.9%
2-point trend, -6.0%
2017-12-31 2018-12-31

Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?

Métrica
Tendência de 5 anos
TDOC
Mediana de Pares
P/E (TTM)
5-point trend, +81.7%
-5.9
39.8
P/S (TTM)
5-point trend, -93.2%
0.5
3.5
P/B
5-point trend, -1.9%
0.9
2.1
Price / FCF (Preço / FCF)
5-point trend, -94.5%
4.2

Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC

Métrica
Tendência de 5 anos
TDOC
Mediana de Pares
Operating Margin (Margem Operacional)
5-point trend, +20.5%
-10.4%
Net Profit Margin (Margem de Lucro Líquido)
5-point trend, +62.4%
-7.9%
1.5%
ROA
5-point trend, -159.5%
-6.3%
0.92%
ROE
5-point trend, -432.5%
-14.3%
3.3%
ROIC
5-point trend, -772.4%
-16.1%

Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial

Métrica
Tendência de 5 anos
TDOC
Mediana de Pares
Current Ratio (Índice de liquidez corrente)
5-point trend, -25.3%
2.8
2.2
Quick Ratio (Índice de Liquidez Seca)
5-point trend, -25.0%
2.4

Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos

Métrica
Tendência de 5 anos
TDOC
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
5-point trend, +24.5%
-1.5%
Revenue CAGR 3Y (CAGR Receita 3A)
5-point trend, +24.5%
1.7%
Revenue CAGR 5Y (CAGR Receita 5A)
5-point trend, +24.5%
18.3%

Métricas por Ação EPS, valor patrimonial por ação, fluxo de caixa por ação, dividendo por ação

Métrica
Tendência de 5 anos
TDOC
Mediana de Pares
EPS (Diluted) (EPS (Diluído))
5-point trend, +58.2%
$-1.14

Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber

Métrica
Tendência de 5 anos
TDOC
Mediana de Pares

TDOC Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta

MANTER 31 analistas
  • Compra forte 4 12,9%
  • Compra 7 22,6%
  • Manter 20 64,5%
  • Venda 0 0,0%
  • Venda forte 0 0,0%

Preço-alvo de 12 meses

19 analistas · 2026-08-14
Alvo mediano $7.50 +13,6%
Alvo médio $7.79 +18,0%

Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados

Surpresa Média
-0.01%
Período EPS Actual EPS est. Surpresa
30 de Junho de 2026 $-0.21 $-0.25 0.04%
31 de Março de 2026 $-0.36 $-0.32 -0.04%
31 de Dezembro de 2025 $-0.14 $-0.19 0.05%
30 de Setembro de 2025 $-0.28 $-0.27 -0.01%
30 de Junho de 2025 $-0.19 $-0.27 0.08%
31 de Março de 2025 $-0.53 $-0.34 -0.19%

Comparação de pares (subindústria GICS) Métricas chave vs pares do setor

Ticker Capitalização de Mercado P/E Receita YoY Margem Líquida ROE Margem Bruta
TDOC $1.25B -6.1 -1.5% -7.9% -14.3%
HTFL $2.49B -9.2 39.9% -66.3% 39.3% 76.8%
SDGR -12.7 23.3% -40.4% -29.2% 55.7%
GDRX 30.1 0.57% 3.8% 4.8%
CERT $1.40B -881.0 8.8% -0.38% -0.15%
HSTM $682M 37.8 4.3% 6.0% 5.2%
PHR 335.8 14.5% 0.48% 0.73%
CTEV $708M -2.5 3.7% -29.4% 265.9%
EVH -0.8 -26.6% -28.5% -81.5%
VEEV $33.40B 37.5 16.3% 28.4% 13.1% 75.5%

Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa

Demonstração de Resultados 18
Dados anuais de Demonstração de Resultados para TDOC
Métrica Tendência 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +5712.3% $2.53B $2.57B $2.60B $2.41B $2.03B $1.09B $553M $418M $233M $123M $77M $44M
Cost of Revenue 9-point trend, +7393.1% · · · $744M $650M $391M $184M $129M $62M $32M $21M $10M
Gross Profit 5-point trend, +760.7% · · · · · · · $289M $172M $91M $56M $34M
R&D Expense 12-point trend, +3569.9% $278M $307M $349M $334M $312M $165M $65M $54M $34M $22M $14M $8M
SG&A Expense 12-point trend, +2341.9% $432M $435M $465M $450M $438M $507M $164M $117M $80M $49M $43M $18M
Operating Expenses 9-point trend, +804.8% $2.79B $3.59B $2.85B $16.06B $2.30B $1.60B $634M $489M $309M · · ·
Operating Income 12-point trend, -1635.7% $-263M $-1.02B $-249M $-13.65B $-266M $-506M $-80M $-71M $-75M $-63M $-56M $-15M
Interest Expense 4-point trend, -70.7% · $24M $22M $22M $81M · · · · · · ·
Interest Income 5-point trend, +4638.4% $37M $57M $47M $13M $776.0K · · · · · · ·
Other Non-op 7-point trend, +2931.9% $10M $-6M $4M $-859.0K $5M $-545.0K $342.0K · · · · ·
Pretax Income 12-point trend, -1314.7% $-236M $-994M $-220M $-13.66B $-385M $-576M $-109M $-97M $-107M $-74M $-58M $-17M
Income Tax 12-point trend, -9174.2% $-35M $8M $760.0K $-4M $44M $-91M $-11M $118.0K $-225.0K $510.0K $36.0K $388.0K
Net Income 12-point trend, -1075.8% $-200M $-1.00B $-220M $-13.66B $-429M $-485M $-99M $-97M $-107M $-74M $-58M $-17M
EPS (Basic) 7-point trend, +17.4% $-1.14 $-5.87 $-1.34 $-84.60 $-2.73 $-5.36 $-1.38 · · · · ·
EPS (Diluted) 7-point trend, +17.4% $-1.14 $-5.87 $-1.34 $-84.60 $-2.73 $-5.36 $-1.38 · · · · ·
Shares (Basic) 7-point trend, +145.3% 176,221,530 170,564,088 164,578,219 161,457,123 156,939,349 90,509,229 71,844,535 · · · · ·
Shares (Diluted) 7-point trend, +145.3% 176,221,530 170,564,088 164,578,219 161,457,123 156,939,349 90,509,229 71,844,535 · · · · ·
EBITDA 10-point trend, -416.4% $-263M $-1.02B $-249M $-13.40B $-61M $-437M $-80M $-35M $-56M · $-51M ·
Balanço Patrimonial 28
Dados anuais de Balanço Patrimonial para TDOC
Métrica Tendência 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +1582.1% $781M $1.30B $1.12B $918M $893M $733M $514M $424M $43M $50M $55M $46M
Short-term Investments 4-point trend, -33.7% · · · · · · · $55M $79M $16M $82M ·
Receivables 12-point trend, +2719.5% $193M $214M $217M $211M $169M $169M $57M $44M $27M $14M $12M $7M
Inventory 7-point trend, +38203000.00 $38M $38M $30M $56M $73M $56M $0 · · · · ·
Prepaid Expense 12-point trend, +10978.3% $107M $113M $118M $130M $87M $47M $14M $11M $7M $3M $2M $966.0K
Other Current Assets 5-point trend, -63.4% $2M $3M $7M $12M $6M · · · · · · ·
Current Assets 12-point trend, +1953.7% $1.12B $1.66B $1.49B $1.32B $1.23B $1.06B $588M $533M $156M $83M $152M $54M
PP&E (Net) 12-point trend, +2432.6% $27M $29M $32M $30M $27M $29M $10M $10M $9M $7M $6M $1M
PP&E (Gross) 12-point trend, +4721.6% $112M $101M $92M $77M $61M $51M $26M $22M $17M $12M $8M $2M
Accum. Depreciation 12-point trend, +6653.2% $85M $71M $60M $48M $34M $22M $16M $12M $8M $4M $2M $1M
Goodwill 12-point trend, +895.3% $283M $283M $1.07B $1.07B $14.50B $14.58B $746M $737M $499M $188M $56M $28M
Intangibles 12-point trend, +17125.6% $1.30B $1.43B $1.68B $1.84B $1.91B $2.02B $225M $247M $160M $25M $15M $8M
Other Non-current Assets 12-point trend, +35644.3% $106M $81M $80M $49M $21M $18M $7M $1M $858.0K $415.0K $293.0K $296.0K
Total Assets 12-point trend, +3012.3% $2.86B $3.52B $4.39B $4.35B $17.73B $17.76B $1.60B $1.53B $824M $304M $230M $92M
Accounts Payable 12-point trend, +2070.5% $48M $33M $44M $48M $47M $46M $9M $8M $4M $2M $2M $2M
Current Liabilities 12-point trend, +3822.3% $405M $942M $421M $400M $331M $333M $90M $62M $40M $21M $18M $10M
Capital Leases 8-point trend, +34204000.00 $34M $32M $43M $38M $42M $43M $25M $0 · · · ·
Deferred Tax 12-point trend, +5905.2% $29M $50M $49M $51M $76M $102M $22M $32M $13M $2M $1M $482.0K
Other Non-current Liabilities 12-point trend, -76.8% $643.0K $720.0K $1M $2M $1M $2M $9M $6M $5M $8M $7M $3M
Total Liabilities 3-point trend, -28.7% $1.47B $2.03B $2.07B · · · · · · · · ·
Long-term Debt 3-point trend, +71.7% · · · · · · · · · $44M $26M $26M
Total Debt 3-point trend, -100.0% · · · · $0 $43M · · · · $26M ·
Common Stock 12-point trend, +8800.0% $178.0K $173.0K $167.0K $163.0K $160.0K $150.0K $73.0K $70.0K $61.0K $46.0K $38.0K $2.0K
Retained Earnings 12-point trend, -22565.5% $-16.43B $-16.23B $-15.23B $-15.01B $-1.42B $-993M $-508M $-409M $-312M $-205M $-131M $-72M
AOCI 11-point trend, -82585.7% $-35M $-38M $-37M $-43M $-6M $19M $-17M $-13M $4M $-1.0K $-42.0K ·
Stockholders' Equity 12-point trend, +2151.8% $1.39B $1.49B $2.33B $2.31B $16.05B $15.88B $1.01B $1.01B $559M $231M $179M $-68M
Liabilities + Equity 12-point trend, +3012.3% $2.86B $3.52B $4.39B $4.35B $17.73B $17.76B $1.60B $1.53B $824M $304M $230M $92M
Shares Outstanding 12-point trend, +8649.5% 178,315,400 173,405,016 166,658,253 162,840,360 160,469,325 150,281,099 72,761,941 70,516,249 61,534,101 46,201,563 38,524,922 2,037,999
Fluxo de Caixa 18
Dados anuais de Fluxo de Caixa para TDOC
Métrica Tendência 202520242023202220212020201920182017201620152014
D&A 9-point trend, +10935.6% · · · $256M $204M $69M $39M $36M $19M $8M $5M $2M
Stock-based Comp 12-point trend, +14987.1% $80M $146M $202M $218M $303M $476M $67M $44M $31M $8M $3M $533.0K
Deferred Tax 12-point trend, -10771.9% $-41M $-1M $-2M $-8M $41M $-91M $-11M $-2M $-591.0K $510.0K $36.0K $388.0K
Amort. of Intangibles 12-point trend, +17438.2% $351M $363M $326M $245M $195M $65M $36M $32M $15M $6M $4M $2M
Restructuring 5-point trend, +1448.6% $19M $20M $17M $7M · · · $1M · · · ·
Other Non-cash 6-point trend, +467012.9% · · · $13.38B $75M $-23M · $15M $23M · $3M ·
Operating Cash Flow 12-point trend, +2691.4% $294M $294M $350M $189M $194M $-54M $30M $-5M $-34M $-52M $-47M $-11M
CapEx 12-point trend, +731.9% $9M $11M $11M $16M $9M $4M $4M $4M $3M $2M $6M $1M
Investing Cash Flow 11-point trend, -145.8% $-266M $-124M $-156M $-168M $-73M $-591M $25M $-257M $-448M $26M $-108M ·
Debt Issued 5-point trend, -99.9% · · · · · · · $10.0K $167M $35M $7M $20M
Net Debt Issued 4-point trend, -100.0% · · · · · · $0 $10.0K $-60M · $468.0K ·
Stock Issued 6-point trend, -100.0% · · · · · $0 $0 $331M $259M $250.0K $163M ·
Stock Repurchased · · · · · · · · · · · $368.0K
Net Stock Activity 4-point trend, -100.0% · · · · · $0 $0 $331M $259M · · ·
Financing Cash Flow 11-point trend, -436.3% $-552M $8M $11M $6M $41M $859M $35M $646M $475M $21M $164M ·
Taxes Paid 9-point trend, +6283.2% $9M $9M $7M $3M $4M $1M $1M $441.0K $137.0K · · ·
Free Cash Flow 10-point trend, +634.0% $285M $283M $339M $173M $185M $-58M $26M $-9M $-37M · $-53M ·
Levered FCF 2-point trend, -18.1% · $259M $316M · · · · · · · · ·
Lucratividade 8
Dados anuais de Lucratividade para TDOC
Métrica Tendência 202520242023202220212020201920182017201620152014
Gross Margin 3-point trend, -5.0% · · · · · · · 69.2% 73.6% · 72.8% ·
Operating Margin 10-point trend, +85.6% -10.4% -39.7% -9.6% -567.3% -13.1% -46.3% -14.5% -17.0% -32.3% · -72.1% ·
Net Margin 10-point trend, +89.4% -7.9% -39.0% -8.5% -567.5% -21.1% -44.4% -17.9% -23.2% -45.8% · -75.0% ·
Pretax Margin 10-point trend, +87.6% -9.3% -38.7% -8.4% -567.7% -18.9% -52.6% -19.8% -23.2% -45.9% · -74.9% ·
EBITDA Margin 10-point trend, +84.2% -10.4% -39.7% -9.6% -556.6% -3.0% -39.9% -14.5% -8.4% -24.1% · -65.8% ·
ROA 10-point trend, +82.6% -6.3% -25.3% -5.0% -123.7% -2.4% -5.0% -6.3% -8.2% -18.9% · -36.1% ·
ROE 10-point trend, +86.3% -14.3% -66.8% -9.5% -326.8% -2.7% -5.4% -9.8% -9.5% -27.0% · -104.5% ·
ROIC 10-point trend, +40.7% -16.1% -69.0% -10.7% -591.5% -1.8% -2.7% -7.2% -7.0% -13.5% · -27.2% ·
Liquidez e Solvência 5
Dados anuais de Liquidez e Solvência para TDOC
Métrica Tendência 202520242023202220212020201920182017201620152014
Current Ratio 10-point trend, -67.2% 2.8 1.8 3.5 3.3 3.7 3.2 6.5 8.5 3.9 · 8.4 ·
Quick Ratio 10-point trend, -71.0% 2.4 1.6 3.2 2.8 3.2 2.7 6.3 8.4 3.7 · 8.3 ·
Debt / Equity 3-point trend, -100.0% · · · · 0.0 0.0 · · · · 0.1 ·
LT Debt / Equity · · · · · · · · · · 0.1 ·
Interest Coverage 2-point trend, -284.5% · -42.9 -11.2 · · · · · · · · ·
Eficiência 3
Dados anuais de Eficiência para TDOC
Métrica Tendência 202520242023202220212020201920182017201620152014
Asset Turnover 10-point trend, +64.9% 0.8 0.6 0.6 0.2 0.1 0.1 0.4 0.4 0.4 · 0.5 ·
Inventory Turnover 3-point trend, -16.9% · · · 11.5 10.0 13.8 · · · · · ·
Receivables Turnover 10-point trend, +52.4% 12.4 11.9 12.2 12.7 12.0 9.7 11.0 11.8 11.4 · 8.2 ·
Por Ação 5
Dados anuais de Por Ação para TDOC
Métrica Tendência 202520242023202220212020201920182017201620152014
Book Value / Share 10-point trend, +67.7% $7.77 $8.60 $13.96 $14.17 $99.99 $105.69 $13.94 $14.37 $9.08 · $4.63 ·
Revenue / Share 5-point trend, +10.8% $14.36 $15.07 $15.81 $14.91 $12.95 · · · · · · ·
Cash Flow / Share 5-point trend, +35.1% $1.67 $1.72 $2.13 $1.17 $1.24 · · · · · · ·
Cash / Share 10-point trend, +206.5% $4.38 $7.49 $6.74 $5.64 $5.57 $4.88 $7.07 $6.01 $0.70 · $1.43 ·
EPS (TTM) 7-point trend, +17.4% $-1.14 $-5.87 $-1.34 $-84.60 $-2.73 $-5.36 $-1.38 · · · · ·
Taxas de Crescimento 3
Dados anuais de Taxas de Crescimento para TDOC
Métrica Tendência 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -101.8% -1.5% -1.3% 8.1% 18.4% 85.8% · · · · · · ·
Revenue CAGR 3Y 3-point trend, -95.0% 1.7% 8.1% 33.5% · · · · · · · · ·
Revenue CAGR 5Y 18.3% · · · · · · · · · · ·
Avaliação (TTM) 13
Dados anuais de Avaliação (TTM) para TDOC
Métrica Tendência 202520242023202220212020201920182017201620152014
Revenue TTM 11-point trend, +3169.4% $2.53B $2.57B $2.60B $2.41B $2.03B $1.09B $553M $418M $233M $123M $77M ·
Net Income TTM 11-point trend, -245.3% $-200M $-1.00B $-220M $-13.66B $-429M $-485M $-99M $-97M $-107M $-74M $-58M ·
Market Cap 10-point trend, +80.4% $1.25B $1.58B $3.59B $3.85B $14.73B $30.05B $6.09B $3.50B $2.14B · $692M ·
Enterprise Value 3-point trend, +2282.1% · · · · $13.84B $29.36B · · · · $581M ·
P/E 7-point trend, +89.9% -6.1 -1.5 -16.1 -0.3 -33.6 -37.3 -60.7 · · · · ·
P/S 10-point trend, -94.5% 0.5 0.6 1.4 1.6 7.2 27.5 11.0 8.4 9.2 · 8.9 ·
P/B 10-point trend, -76.8% 0.9 1.1 1.5 1.7 0.9 1.9 6.0 3.5 3.8 · 3.9 ·
P / Cash Flow 10-point trend, +128.9% 4.2 5.4 10.3 20.3 76.0 -561.6 203.9 -719.2 -62.3 · -14.7 ·
P / FCF 10-point trend, +133.8% 4.4 5.6 10.6 22.3 79.4 -522.3 231.1 -394.0 -57.8 · -12.9 ·
EV / EBITDA 3-point trend, -1875.8% · · · · -225.4 -67.2 · · · · -11.4 ·
EV / FCF 3-point trend, +786.6% · · · · 74.6 -510.3 · · · · -10.9 ·
EV / Revenue 3-point trend, -9.3% · · · · 6.8 26.8 · · · · 7.5 ·
Earnings Yield 7-point trend, -887.3% -16.3% -64.6% -6.2% -357.7% -3.0% -2.7% -1.7% · · · · ·

Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos

Demonstração de Resultados
2025-12-312024-12-312023-12-312022-12-312021-12-31
Receita $2.53B$2.57B$2.60B$2.41B$2.03B
Margem Operacional % -10.4%-39.7%-9.6%-567.3%-13.1%
Lucro líquido $-200M$-1.00B$-220M$-13.66B$-429M
EPS Diluído $-1.14$-5.87$-1.34$-84.60$-2.73
Balanço Patrimonial
2025-12-312024-12-312023-12-312022-12-312021-12-31
Dívida / Patrimônio Líquido 0.0
Índice de liquidez corrente 2.81.83.53.33.7
Índice de Liquidez Seca 2.41.63.22.83.2
Fluxo de Caixa
2025-12-312024-12-312023-12-312022-12-312021-12-31
Fluxo de caixa livre $285M$283M$339M$173M$185M

Últimas notícias Notícias recentes mencionando esta empresa

Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos

📊

Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.

Sua seleção é salva e acompanha você em todos os tickers.

Investidores institucionais (13F) 398 declarantes · $1.2B total · Em 30 de Junho de 2026

Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.

Atividade institucional — Q2 2026 vs trimestre anterior
Novas posições Posições encerradas Aumentou Diminuído Variação líquida de ações
73 (+11 vs trimestre anterior) 33 (-40 vs trimestre anterior) 104 (-10 vs trimestre anterior) 88 (+3 vs trimestre anterior) +36.3M

Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.

Instituição Valor Ações % de 13F rastreado Tipo
VANGUARD GROUP INC $139.930.938 19.990.134 11,50% Ações
VANGUARD PORTFOLIO MANAGEMENT LLC $107.573.820 12.685.592 8,84% Ações
Point72 Asset Management, L.P. $69.874.581 8.239.927 5,74% Ações
RENAISSANCE TECHNOLOGIES LLC $68.457.700 8.072.842 5,63% Ações
Voss Capital, LP $68.235.838 8.046.679 5,61% Ações
VANGUARD CAPITAL MANAGEMENT LLC $67.458.671 7.955.032 5,55% Ações
DIMENSIONAL FUND ADVISORS LP $59.415.442 7.006.538 4,88% Ações
STATE STREET CORP $42.080.999 4.962.382 3,46% Ações
AMERICAN CENTURY COMPANIES INC $41.505.394 4.894.504 3,41% Ações
Allianz Asset Management GmbH $39.572.734 4.666.596 3,25% Ações
GEODE CAPITAL MANAGEMENT, LLC $33.651.520 3.967.415 2,77% Ações
Monaco Asset Management SAM $26.864.462 3.167.979 2,21% Ações
JUPITER ASSET MANAGEMENT LTD $26.370.375 3.109.714 2,17% Ações
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $25.976.377 3.063.252 2,14% Ações
GOLDMAN SACHS GROUP INC $25.430.579 2.998.889 2,09% Ações
Quantinno Capital Management LP $23.904.416 2.818.917 1,97% Ações
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $17.299.632 2.040.051 1,42% Ações
AMERIPRISE FINANCIAL INC $16.946.398 1.998.396 1,39% Ações
Pale Fire Capital SE $16.737.502 1.973.762 1,38% Ações
SUSQUEHANNA INTERNATIONAL GROUP, LLP $16.435.088 1.938.100 1,35% Opção de compra
SUSQUEHANNA INTERNATIONAL GROUP, LLP $11.710.032 1.380.900 0,96% Opção de venda
BRIDGEWAY CAPITAL MANAGEMENT, LLC $11.348.708 1.338.291 0,93% Ações
VANGUARD FIDUCIARY TRUST CO $10.120.074 1.193.405 0,83% Ações
BNP PARIBAS FINANCIAL MARKETS $9.796.800 1.155.283 0,81% Ações
Freestone Grove Partners LP $7.338.160 865.349 0,60% Ações
Man Group plc $6.880.545 811.385 0,57% Ações
PRINCIPAL FINANCIAL GROUP INC $6.795.228 801.324 0,56% Ações
CITADEL ADVISORS LLC $6.795.024 801.300 0,56% Opção de venda
Union Square Park Capital Management, LLC $6.784.000 800.000 0,56% Ações
CITADEL ADVISORS LLC $6.532.093 770.294 0,54% Ações
FMR LLC $6.418.334 756.879 0,53% Ações
TCW GROUP INC $6.248.039 736.797 0,51% Ações
Voss Capital, LP $5.936.000 700.000 0,49% Opção de compra
Empowered Funds, LLC $5.764.619 679.790 0,47% Ações
PEAK6 LLC $5.227.920 616.500 0,43% Opção de compra
CITADEL ADVISORS LLC $5.114.288 603.100 0,42% Opção de compra
Squarepoint Ops LLC $5.089.696 600.200 0,42% Opção de compra
JANE STREET GROUP, LLC $5.088.848 600.100 0,42% Opção de venda
FRANKLIN RESOURCES INC $4.518.161 532.802 0,37% Ações
TWO SIGMA ADVISERS, LP $4.211.319 601.617 0,35% Ações
Universal- Beteiligungs- und Servicegesellschaft mbH $3.700.706 436.404 0,30% Ações
WOLVERINE TRADING, LLC $3.607.180 439.900 0,30% Opção de compra
Parallax Volatility Advisers, L.P. $3.392.000 400.000 0,28% Opção de compra
TUDOR INVESTMENT CORP ET AL $3.288.603 387.807 0,27% Ações
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main $3.248.866 383.121 0,27% Ações
Swiss National Bank $3.035.857 358.002 0,25% Ações
BANK OF AMERICA CORP /DE/ $2.894.928 341.383 0,24% Ações
ALLIANCEBERNSTEIN L.P. $2.781.435 510.355 0,23% Ações
Squarepoint Ops LLC $2.761.936 325.700 0,23% Opção de venda
Trexquant Investment LP $2.755.932 324.992 0,23% Ações
D. E. Shaw & Co., Inc. $2.544.000 300.000 0,21% Opção de venda
ORACLE INVESTMENT MANAGEMENT INC $2.480.366 354.338 0,20% Ações
Soviero Asset Management, LP $2.442.240 288.000 0,20% Opção de compra
D. E. Shaw & Co., Inc. $2.371.941 279.710 0,20% Ações
BlackRock, Inc. $2.312.106 272.654 0,19% Ações
IEQ CAPITAL, LLC $2.273.165 268.062 0,19% Ações
JANE STREET GROUP, LLC $2.155.616 254.200 0,18% Opção de compra
WOLVERINE TRADING, LLC $2.059.020 251.100 0,17% Opção de venda
RHUMBLINE ADVISERS $2.058.803 242.785 0,17% Ações
Walleye Trading LLC $2.017.188 237.876 0,17% Ações
WINTON GROUP Ltd $1.925.808 227.100 0,16% Ações
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $1.906.796 224.858 0,16% Ações
Brevan Howard Capital Management LP $1.880.084 221.708 0,15% Ações
VIRGINIA RETIREMENT SYSTEMS ET Al $1.704.675 243.525 0,14% Ações
UBS Group AG $1.696.000 200.000 0,14% Opção de compra
NOMURA HOLDINGS INC $1.696.000 200.000 0,14% Opção de venda
Parker Investment Management, LLC $1.586.515 187.089 0,13% Ações
OPPENHEIMER & CO INC $1.571.268 185.291 0,13% Ações
ABS Direct Equity Fund LLC $1.513.154 178.438 0,12% Ações
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $1.495.703 274.441 0,12% Ações
Summit Trail Advisors, LLC $1.488.766 175.562 0,12% Ações
NANO CAP NEW MILLENNIUM GROWTH FUND L P $1.484.000 175.000 0,12% Ações
SIMPLEX TRADING, LLC $1.396.808 164.718 0,11% Ações
BARCLAYS PLC $1.347.861 158.946 0,11% Ações
NATIXIS $1.347.472 158.900 0,11% Ações
WELLS FARGO & COMPANY/MN $1.346.183 158.748 0,11% Ações
JENNISON ASSOCIATES LLC $1.333.793 157.287 0,11% Ações
Rock Creek Group LLC $1.329.944 156.833 0,11% Ações
MACKENZIE FINANCIAL CORP $1.297.381 152.993 0,11% Ações
Walleye Trading LLC $1.277.936 150.700 0,11% Opção de venda
Counterpoint Mutual Funds LLC $1.252.301 147.677 0,10% Ações
MILLENNIUM MANAGEMENT LLC $1.233.111 145.414 0,10% Ações
Balyasny Asset Management L.P. $1.226.208 144.600 0,10% Opção de venda
TWO SIGMA INVESTMENTS, LP $1.217.245 143.543 0,10% Ações
ALGERT GLOBAL LLC $1.211.792 142.900 0,10% Ações
Engineers Gate Manager LP $1.204.499 142.040 0,10% Ações
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $1.187.666 140.055 0,10% Ações
Walleye Capital LLC $1.082.896 127.700 0,09% Opção de compra
Leonteq Securities AG $1.064.384 125.517 0,09% Ações
VANGUARD ASSET MANAGEMENT, Ltd $1.045.813 123.327 0,09% Ações
JANUS HENDERSON GROUP PLC $1.038.988 190.640 0,09% Ações
Walleye Capital LLC $989.616 116.700 0,08% Opção de venda
Crawford Fund Management, LLC $987.072 116.400 0,08% Opção de venda
OP Asset Management Ltd $958.969 113.086 0,08% Ações
Vanguard Global Advisers, LLC $932.469 109.961 0,08% Ações
CHIRON CAPITAL MANAGEMENT, LLC $930.850 109.770 0,08% Ações
Jefferies Financial Group Inc. $907.657 107.035 0,07% Ações
MetLife Investment Management, LLC $901.746 106.338 0,07% Ações
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC $891.845 96.104 0,07% Ações
Y-Intercept (Hong Kong) Ltd $876.815 103.398 0,07% Ações

Executivos da empresa 48 insiders · 23 diretores · 22 conselheiros

Investidor com informação privilegiada Função Última atividade Ações detidas Compras 12m Vendas 12m Líquido 12m
Charles Divita III CHIEF EXECUTIVE OFFICER 10 de Junho de 2026 M 414.622 0 6 $-938.572
Jason N Gorevic Chief Executive Officer 4 de Março de 2022 M 516.464 0 0 $0
Mala Murthy Chief Financial Officer 1 de Março de 2022 A 17.357 0 0 $0
Mark Hirschhorn Executive VP, COO and CFO 13 de Dezembro de 2018 M 10.000 0 0 $0
Kelly Bliss President, U.S. Group Health 6 de Julho de 2026 S 84.878 0 4 $-126.068
Fernando M. Rodrigues President of BetterHelp 3 de Junho de 2026 S 0 0 2 $-114.131
Carlos Nueno President, International 1 de Junho de 2026 M 57.671 0 1 $-47.257
Peter A Mcclennen President 15 de Julho de 2019 M 0 0 0 $0
David William Sides Chief Operating Officer 29 de Julho de 2021 M 11.031 0 0 $0
Joseph Ronald Catapano Chief Accounting Officer 1 de Julho de 2026 M 12.267 0 2 $-8.108
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY 1 de Junho de 2026 M 110.261 0 3 $-241.831
Daniel Trencher SVP Corporate Strategy 4 de Março de 2022 M 29.408 0 0 $0
Stephany Verstraete Chief Marketing Officer 4 de Março de 2022 M 31.828 0 0 $0
Andrew Turitz SVP - Business Development 4 de Março de 2022 M 14.794 0 0 $0
Claus Torp Jensen Chief Innovation Officer 1 de Março de 2022 A 0 0 $0
Arnnon Geshuri Chief Human Resources Officer 1 de Março de 2022 A 83.168 0 0 $0
Richard J Napolitano Chief Accounting Officer 1 de Março de 2022 A 1.195 0 0 $0
Lewis Levy Chief Medical Officer 1 de Outubro de 2020 M 8.766 0 0 $0
Michelle Bucaria Chief Human Resources Officer 1 de Setembro de 2020 M 3.232 0 0 $0
Christopher Caridi Chief Accounting Officer 1 de Julho de 2020 A 0 0 $0
Gabriel R. Cappucci Senior VP, Controller and CAO 16 de Abril de 2020 M 988 0 0 $0
Michael H. King Chief Sales Officer 25 de Maio de 2017 A 61.459 0 0 $0
Peter N. Nieves EVP and CRO 13 de Março de 2017 A 0 0 $0
Mark V Anquillare Conselheiro 3 de Agosto de 2026 A 0 0 $0
David B Snow JR Conselheiro 21 de Maio de 2026 A 113.032 0 0 $0
David L Shedlarz Conselheiro 21 de Maio de 2026 A 61.266 0 0 $0
Susan R Salka Conselheiro 30 de Março de 2026 A 0 0 $0
Catherine Jacobson Conselheiro 18 de Fevereiro de 2022 M 1.468 0 0 $0
William H. Frist Conselheiro 15 de Setembro de 2021 M 12.918 0 0 $0
Karen L Daniel Conselheiro 25 de Agosto de 2021 M 41.915 0 0 $0
Christopher Bischoff Conselheiro 25 de Maio de 2021 M 5.121 0 0 $0
Mark Douglas Smith Conselheiro 17 de Maio de 2021 A 3.536 0 0 $0
Kenneth H Paulus Conselheiro 17 de Maio de 2021 A 0 0 0 $0
Thomas Mckinley Conselheiro 17 de Maio de 2021 A 5.879 0 0 $0
Hemant Taneja Conselheiro 19 de Abril de 2021 S 118.760 0 0 $0
Glen Tullman Conselheiro 1 de Abril de 2021 M 275.793 0 0 $0
Helen Darling Conselheiro 11 de Junho de 2020 M 918 0 0 $0
Arneek Multani Conselheiro 30 de Maio de 2019 A 918 0 0 $0
Brian P Mcandrews Conselheiro 30 de Maio de 2019 A 1.965 0 0 $0
Tom Mawhinney Conselheiro 25 de Maio de 2018 M 46.203 0 0 $0
Martin R Felsenthal Conselheiro 8 de Agosto de 2016 A 10.860 0 0 $0
Dana G Mead Jr. Conselheiro 8 de Agosto de 2016 A 202 0 0 $0
James K Outland Conselheiro 13 de Julho de 2015 M 49.986 0 0 $0
CHP III Management, L.L.C. Detentor de 10% 26 de Abril de 2017 J 2.480.468 0 0 $0
CHP III LP Detentor de 10% 26 de Abril de 2017 J 2.480.468 0 0 $0
Sandra L Fenwick 21 de Maio de 2026 A 10.762 0 0 $0
Yulun Wang 25 de Janeiro de 2021 S 219.507 0 0 $0
Michael Goldstein 11 de Junho de 2020 M 0 0 0 $0

Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto

Ativistas e proprietários de 5%+ 2 participações

Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.

Declarante Declarado Participação Status Propósito Declaração
Kinnevik AB (publ), Invik S.A. ×3 declarações 15 de Abril de 2021 Declaração inicial SEC
General Catalyst Group Management Holdings GP, LLC, General Catalyst Group Management Holdings, L.P., General Catalyst Group Management, LLC, General Catalyst Group VI, L.P., General Catalyst Partners VI, L.P., General Catalyst GP VI, LLC, General Catalyst Group VIII, L.P., General Catalyst Group VIII Supplemental, L.P., General Catalyst Partners VIII, L.P., General Catalyst GP VIII, LLC, GC Partners Holdings, LP, GCSE VIII, L.P., GCSE VIII, LLC, GCGM Investment Holdings, LP, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow, Hemant Taneja ×3 declarações 16 de Março de 2021 Declaração inicial SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Participação em ETFs Detido por 55 ETFs

O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.

Fundo Peso Unidades Em Fonte
HEAL · Global X Funds 1,18% 38.782 NS 31 de Maio de 2026 N-PORT
SVAL · iShares Trust 0,42% 129.925 SH 8 de Agosto de 2026 Diário
JSML · Janus Detroit Street Trust 0,34% 178.607 NS 30 de Abril de 2026 N-PORT
GSSC · Goldman Sachs ETF Trust 0,20% 261.035 NS 31 de Maio de 2026 N-PORT
FSCC · Federated Hermes ETF Trust 0,18% 66.764 NS 31 de Maio de 2026 N-PORT
IHF · iShares Trust 0,18% 332.174 SH 8 de Agosto de 2026 Diário
VTWV · VANGUARD SCOTTSDALE FUNDS 0,10% 159.976 SH 8 de Agosto de 2026 Diário
SMLF · iShares Trust 0,09% 592.154 SH 8 de Agosto de 2026 Diário
FNDA · SCHWAB STRATEGIC TRUST 0,08% 978.669 NS 31 de Maio de 2026 N-PORT
AVUV · AMERICAN CENTURY ETF TRUST 0,08% 2.910.344 NS 31 de Maio de 2026 N-PORT
IWN · iShares Trust 0,08% 1.690.654 SH 8 de Agosto de 2026 Diário
GINN · Goldman Sachs ETF Trust 0,08% 21.242 NS 31 de Maio de 2026 N-PORT
DFSV · Dimensional ETF Trust 0,07% 920.742 NS 30 de Abril de 2026 N-PORT
NUSC · Nushares ETF Trust 0,07% 155.542 NS 30 de Abril de 2026 N-PORT
AVSC · AMERICAN CENTURY ETF TRUST 0,07% 252.145 NS 31 de Maio de 2026 N-PORT
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0,06% 67.673 NS 30 de Abril de 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,05% 1.047.849 SH 8 de Agosto de 2026 Diário
VFMF · VANGUARD WELLINGTON FUND 0,04% 29.737 SH 8 de Agosto de 2026 Diário
IWM · iShares Trust 0,04% 4.666.989 SH 8 de Agosto de 2026 Diário
ISCV · iShares Trust 0,04% 38.629 SH 8 de Agosto de 2026 Diário
PNQI · Invesco Exchange-Traded Fund Trust 0,04% 26.986 SH 8 de Agosto de 2026 Diário
ITWO · ProShares Trust 0,03% 8.377 NS 31 de Maio de 2026 N-PORT
RSSL · Global X Funds 0,03% 77.120 NS 30 de Abril de 2026 N-PORT
VBR · VANGUARD INDEX FUNDS 0,03% 2.631.374 SH 8 de Agosto de 2026 Diário
SCHA · SCHWAB STRATEGIC TRUST 0,03% 858.463 NS 31 de Maio de 2026 N-PORT
DFAS · Dimensional ETF Trust 0,03% 584.184 NS 30 de Abril de 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,02% 2.084.219 SH 8 de Agosto de 2026 Diário
VB · VANGUARD INDEX FUNDS 0,02% 4.153.113 SH 8 de Agosto de 2026 Diário
UWM · ProShares Trust 0,02% 6.552 NS 31 de Maio de 2026 N-PORT
VHT · VANGUARD WORLD FUND 0,02% 535.056 SH 8 de Agosto de 2026 Diário
ISCB · iShares Trust 0,02% 7.717 SH 8 de Agosto de 2026 Diário
FHLC · FIDELITY COVINGTON TRUST 0,02% 81.058 NS 30 de Abril de 2026 N-PORT
DXUV · Dimensional ETF Trust 0,02% 10.585 NS 30 de Abril de 2026 N-PORT
URTY · ProShares Trust 0,01% 6.629 NS 31 de Maio de 2026 N-PORT
DFAT · Dimensional ETF Trust 0,01% 285.019 NS 30 de Abril de 2026 N-PORT
PRF · Invesco Exchange-Traded Fund Trust 0,01% 170.044 SH 8 de Agosto de 2026 Diário
WSML · iShares Trust 0,01% 10.387 SH 8 de Agosto de 2026 Diário
TILT · FlexShares Trust 0,01% 34.034 NS 30 de Abril de 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0,01% 6.863 NS 31 de Maio de 2026 N-PORT
HDG · ProShares Trust 0,01% 166 NS 31 de Maio de 2026 N-PORT
DFAC · Dimensional ETF Trust 0,01% 422.235 NS 30 de Abril de 2026 N-PORT
FNDB · SCHWAB STRATEGIC TRUST 0,01% 9.970 NS 31 de Maio de 2026 N-PORT
AVUQ · AMERICAN CENTURY ETF TRUST 0,01% 1.783 NS 31 de Maio de 2026 N-PORT
DCOR · Dimensional ETF Trust 0,00% 22.871 NS 30 de Abril de 2026 N-PORT
DFSU · Dimensional ETF Trust 0,00% 11.743 NS 30 de Abril de 2026 N-PORT
DSI · iShares Trust 0,00% 25.216 SH 8 de Agosto de 2026 Diário
AVUS · AMERICAN CENTURY ETF TRUST 0,00% 42.456 NS 31 de Maio de 2026 N-PORT
SCHB · SCHWAB STRATEGIC TRUST 0,00% 105.579 NS 31 de Maio de 2026 N-PORT
ITOT · iShares Trust 0,00% 232.888 SH 8 de Agosto de 2026 Diário
IWV · iShares Trust 0,00% 45.271 SH 8 de Agosto de 2026 Diário